Genetic interventions for vein bypass graft disease: A review

被引:29
作者
Conte, MS
Mann, MJ
Simosa, HF
Rhynhart, KK
Mulligan, RC
机构
[1] Brigham & Womens Hosp, Div Vasc Surg, Dept Surg, Boston, MA 02115 USA
[2] Harvard Univ, Inst Human Genet, Boston, MA 02115 USA
关键词
D O I
10.1067/mva.2002.129112
中图分类号
R61 [外科手术学];
学科分类号
摘要
The failure of vein bypass grafting in the coronary or lower extremity circulation is a common clinical occurrence that incurs significant morbidity, mortality, and cost. Vein grafts are uniquely amenable to intraoperative genetic modification because of the ability to manipulate the tissue ex vivo with controlled conditions. Although the pathophysiology of vein graft failure is incompletely understood, numerous relevant molecular targets have been elucidated. Interventions designed to influence cell proliferation, thrombosis, inflammation, and matrix remodeling at the genetic level have been described, and many have been tested in animal models. Both gene delivery and gene blockade strategies have been investigated, with the latter now reaching the stage of advanced clinical trials. This review describes the basic and translational science of genetic interventions for vein graft disease and the current state of application in the clinic.
引用
收藏
页码:1040 / 1052
页数:13
相关论文
共 146 条
[31]   Heme oxygenase-1 protects against vascular constriction and proliferation [J].
Duckers, HJ ;
Boehm, M ;
True, AL ;
Yet, SF ;
San, H ;
Park, JL ;
Webb, RC ;
Lee, ME ;
Nabel, GJ ;
Nabel, EG .
NATURE MEDICINE, 2001, 7 (06) :693-698
[32]   Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy [J].
Ehsan, A ;
Mann, MJ ;
Dell'Acqua, G ;
Dzau, VJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 121 (04) :714-722
[33]   PROTECTION OF HUMAN ENDOTHELIAL-CELLS FROM OXIDANT INJURY BY ADENOVIRUS-MEDIATED TRANSFER OF THE HUMAN CATALASE CDNA [J].
ERZURUM, SC ;
LEMARCHAND, P ;
ROSENFELD, MA ;
YOO, JH ;
CRYSTAL, RG .
NUCLEIC ACIDS RESEARCH, 1993, 21 (07) :1607-1612
[34]   Monocyte adhesion to human vein grafts: A marker for occult intraoperative injury? [J].
Eslami, MH ;
Gangadharan, SP ;
Belkin, M ;
Donaldson, MC ;
Whittemore, AD ;
Conte, MS .
JOURNAL OF VASCULAR SURGERY, 2001, 34 (05) :923-928
[35]   Gene delivery to in situ veins: Differential effects of adenovirus and adeno-associated viral vectors [J].
Eslami, MH ;
Gangadharan, SP ;
Sui, X ;
Rhynhart, KK ;
Snyder, RO ;
Conte, MS .
JOURNAL OF VASCULAR SURGERY, 2000, 31 (06) :1149-1159
[36]   Modulation of matrix metalloproteinase activity in human saphenous vein grafts using adenovirus-mediated gene transfer [J].
Fernandez, HA ;
Kallenbach, K ;
Seghezzi, G ;
Mehrara, B ;
Apazidis, A ;
Baumann, FG ;
Grossi, EA ;
Colvin, S ;
Mignatti, P ;
Galloway, AC .
SURGERY, 1998, 124 (02) :129-136
[37]   Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors [J].
Ferrari, FK ;
Samulski, T ;
Shenk, T ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3227-3234
[38]   VEIN ADAPTATION TO THE HEMODYNAMIC ENVIRONMENT OF INFRAINGUINAL GRAFTS [J].
FILLINGER, MF ;
CRONENWETT, JL ;
BESSO, S ;
WALSH, DB ;
ZWOLAK, RM .
JOURNAL OF VASCULAR SURGERY, 1994, 19 (06) :970-979
[39]   Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis [J].
Fisher, KJ ;
Gao, GP ;
Weitzman, MD ;
DeMatteo, R ;
Burda, JF ;
Wilson, JM .
JOURNAL OF VIROLOGY, 1996, 70 (01) :520-532
[40]   Gene therapy enhances the antiproliferative effect of radiation in intimal hyperplasia [J].
Fortunato, JE ;
Mauceri, HJ ;
Kocharyan, H ;
Song, RH ;
Salloum, R ;
Vosicky, J ;
Swedberg, K ;
Malik, S ;
Abusharif, F ;
Glagov, S ;
Weichselbaum, RR ;
Bassiouny, HS .
JOURNAL OF SURGICAL RESEARCH, 2000, 89 (02) :155-162